Literature DB >> 15858401

Spinal muscular atrophy: a delayed development hypothesis.

Irena Hausmanowa-Petrusewicz1, Gerta Vrbová.   

Abstract

Spinal muscular atrophy is an inherited neuromuscular disorder. The gene responsible for the disease has been identified and named the SMN gene. This review is prompted by recent advances in understanding cellular function of the SMN gene and its gene product and by the increasing evidence that maturation of all parts of the neuromuscular system is delayed in spinal muscular atrophy patients. We suggest that the timing of developmental changes in motoneurons and muscles is critical for their survival. Delayed maturation of either motoneuron or muscle can cause these cells to die so the molecules that are involved in controlling their rate of maturation are crucial for normal development. We suggest that SMN gene/protein is one such molecule, because the neuromuscular system develops more slowly in spinal muscular atrophy patients, where SMN protein is absent, and in animals models, where SMN protein is reduced.

Entities:  

Mesh:

Year:  2005        PMID: 15858401     DOI: 10.1097/00001756-200505120-00001

Source DB:  PubMed          Journal:  Neuroreport        ISSN: 0959-4965            Impact factor:   1.837


  13 in total

1.  Muscles in a mouse model of spinal muscular atrophy show profound defects in neuromuscular development even in the absence of failure in neuromuscular transmission or loss of motor neurons.

Authors:  Young Il Lee; Michelle Mikesh; Ian Smith; Mendell Rimer; Wesley Thompson
Journal:  Dev Biol       Date:  2011-05-30       Impact factor: 3.582

2.  Deficiency of the zinc finger protein ZPR1 causes neurodegeneration.

Authors:  Beth Doran; Norberto Gherbesi; Gregory Hendricks; Richard A Flavell; Roger J Davis; Laxman Gangwani
Journal:  Proc Natl Acad Sci U S A       Date:  2006-04-28       Impact factor: 11.205

3.  Compensatory axon sprouting for very slow axonal die-back in a transgenic model of spinal muscular atrophy type III.

Authors:  Esther Udina; Charles T Putman; Luke R Harris; Neil Tyreman; Victoria E Cook; Tessa Gordon
Journal:  J Physiol       Date:  2017-01-25       Impact factor: 5.182

4.  Severe neuromuscular denervation of clinically relevant muscles in a mouse model of spinal muscular atrophy.

Authors:  Karen K Y Ling; Rebecca M Gibbs; Zhihua Feng; Chien-Ping Ko
Journal:  Hum Mol Genet       Date:  2011-10-03       Impact factor: 6.150

5.  Spectrum of neuropathophysiology in spinal muscular atrophy type I.

Authors:  Brian N Harding; Shingo Kariya; Umrao R Monani; Wendy K Chung; Maryjane Benton; Sabrina W Yum; Gihan Tennekoon; Richard S Finkel
Journal:  J Neuropathol Exp Neurol       Date:  2015-01       Impact factor: 3.685

6.  Cardiomyopathy in motor neuron diseases.

Authors:  H-J Gdynia; A Kurt; S Endruhn; A C Ludolph; A-D Sperfeld
Journal:  J Neurol Neurosurg Psychiatry       Date:  2006-05       Impact factor: 10.154

Review 7.  Congenital bone fractures in spinal muscular atrophy: functional role for SMN protein in bone remodeling.

Authors:  Srinivasan Shanmugarajan; Kathryn J Swoboda; Susan T Iannaccone; William L Ries; Bernard L Maria; Sakamuri V Reddy
Journal:  J Child Neurol       Date:  2007-08       Impact factor: 1.987

8.  Abnormal motor phenotype in the SMNDelta7 mouse model of spinal muscular atrophy.

Authors:  Matthew E R Butchbach; Jonathan D Edwards; Arthur H M Burghes
Journal:  Neurobiol Dis       Date:  2007-05-05       Impact factor: 5.996

9.  Spinal muscular atrophy and a model for survival of motor neuron protein function in axonal ribonucleoprotein complexes.

Authors:  Wilfried Rossoll; Gary J Bassell
Journal:  Results Probl Cell Differ       Date:  2009

10.  Embryonic motor axon development in the severe SMA mouse.

Authors:  Vicki L McGovern; Tatiana O Gavrilina; Christine E Beattie; Arthur H M Burghes
Journal:  Hum Mol Genet       Date:  2008-07-03       Impact factor: 6.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.